NPPES file of Aug 9, 2026

Sara Kazemeyni Monfared, RPH

Pharmacist · Las Vegas, NV

Sara Kazemeyni Monfared, RPH is a pharmacist with a practice address in Las Vegas, Nevada, and NPI 1982980140, issued on Nov 1, 2011. Check the license (Nevada 15922, as entered in NPPES) with the Nevada board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1982980140
Name
Sara Kazemeyni Monfared
Credential
RPH
Primary taxonomy
Pharmacist 183500000X
License number
15922 NV
Self-reported in NPPES; status is on the state search
Practice location
8500 W Cheyenne Ave, Las Vegas, NV 89129
Phone
(702) 655-7258
Enumerated
Nov 1, 2011
Record last updated
Nov 1, 2011 (not updated in 15 years: call before relying on the address or phone)
Fax
(702) 655-7295
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 8500 W Cheyenne Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Tricia AsadaPharmacist1215309026
  2. Thomas Beierwaltes, PHARM-DPharmacist1144505090
  3. Ted Cheng, PHARMDPharmacist1538578703
  4. Beverly Driskill, APNPsychiatric/Mental Health Nurse Practitioner1689762122
  5. Melinda Duncan, RPHPharmacist1548544927
  6. Jackie LapointePharmacy Technician1871345611

Verify Sara Kazemeyni Monfared in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich Nevada board licenses this profession
    Search for license 15922
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the Nevada license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

Most of these Medicare Part D claims are vaccines, 100% of the cost of the top drugs

47 Medicare Part D claims for 43 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.

  1. Sara Kazemeyni Monfared47
  2. Specialty average119

Most prescribed

Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.

  1. Shingrix18 claims
  2. Abrysvo17 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Sara Kazemeyni Monfared among 2,090 pharmacist records in Nevada

Sara Kazemeyni Monfared, RPH is one of 2,090 pharmacist records with a practice address in Nevada. 4% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2011, is newer than 13% of them.

  • NPI issued2011 · 13% of these records are older, 72% newer
  • In a Medicare fileYes · 4% of these records are
  • In the CMS Doctors and Clinicians fileNo · 0% of these records are
  • Record last updated2011 · 71% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 183500000X and a Nevada practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

966 pharmacist records list a practice address in Las Vegas

They are 966 of the 65,269 NPPES records with a practice address in Las Vegas, and 2,090 pharmacist records in Nevada.

The 8 pharmacist records with the nearest ZIP codes

  1. Willie BawarskiLas Vegas, NV 891291689959157
  2. Thomas Beierwaltes, PHARM-DLas Vegas, NV 891291144505090
  3. Melinda Duncan, RPHLas Vegas, NV 891291548544927
  4. Donald Gitersonke, RPH, MBALas Vegas, NV 891291013133784
  5. Daniel Krygiell, RPHLas Vegas, NV 891291407138548
  6. Ryan Lizardo, PHARM DLas Vegas, NV 891291902129034
  7. Linda Mordente-Flynn, RPHLas Vegas, NV 891291306057088
  8. Sharon Navalta, RPHLas Vegas, NV 891291184909277

Common questions

What is Sara Kazemeyni Monfared, RPH's NPI number?

Sara Kazemeyni Monfared, RPH's National Provider Identifier (NPI) is 1982980140, issued on Nov 1, 2011. An NPI identifies a provider in billing; it is not a license.

Where is Sara Kazemeyni Monfared, RPH located?

The NPPES record lists a practice address at 8500 W Cheyenne Ave, Las Vegas, NV, 89129. Phone: (702) 655-7258. Providers update this record themselves, so call before visiting.

How can I verify Sara Kazemeyni Monfared, RPH's license?

NPPES lists Nevada license number 15922, as entered by the provider. Search the Nevada board that licenses this profession; the NPPES record confirms identity only.

How much does Sara Kazemeyni Monfared, RPH prescribe under Medicare Part D?

In 2024, Sara Kazemeyni Monfared, RPH had 47 Medicare Part D claims for 43 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.